Is B-IBD expected to be a treatment that will have to be
Is B-IBD expected to be a treatment that will have to be taken for life to combat IBD conditions already in the body or, once the condition is cleared, does the underlying issue that caused the condition end so the patient can stop taking B-IBD?
Could there be a preventative treatment for infants to prevent IBD conditions from beginning? Would be nice to think it could work like the regular shots infants get early in life to prevent serious conditions from arising. Also would be nice for shareholders if it should become standard issue for all babies in the future.
I am not medically trained so this entire post postulates my WAGs regarding possible uses and delivery systems for Brilacidin.
From what I get regarding microtablets, IPIX could have a family of capsules for IBD issues (one for UC for early in the intestines, than one for Crohn's a little later in the intestines, and finally one for sigmoidcolitis for the end of the intestines and this one may be used in conjunction with a foam/get applied directly into the rectum). There could also be a capsule for B to target needs in areas of the body other than the intestines and needing quick absorption into the bloodstream. Thinking of maybe a two-sided treatment for skin conditions with a capsule being used in tandem with a topical cream. Don't know what delivery system would be used for problems of the throat down to the GI tract entering the stomach.
Brilacidin IMO is akin to a prospector being at the entrance to the Lost Dutchman Mine. Going to take time to get a grasp on the entire system but every shaft explored should produce gold in varying amounts. Seems impossible to believe that an astute BP doesn't see the possibilities of this drug in addition to the already proven results for OM, IBD, and ABSSSI and is about to step up to the plate and claim this potentially company-changing drug for themselves. Get 'er done!!
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Data4Life and EvidNet: A New Era in Health Research In a groundbreaking collaboration, the nonprofit digital health organization Data4Life has teamed up with South Korea's leading federated research platform, EvidNet. This strategic partnership aims to co-develop a global infrastructure dedicated to federated real-world evidence (RWE) generation, setting a new standard...
Continue Reading
Sky Quarry Seeks Recycling Permit for Integrated Facility Sky Quarry Inc. (NASDAQ: SKYQ) is making strides in the integrated energy sector with its recent announcement regarding a Waste Management Recycling Permit application. This filing is particularly important for the company as it aims to revolutionize the waste asphalt shingle recycling industry. If approved, this...
Continue Reading
TechCXO Launches Its Redesigned Website TechCXO, a leader in on-demand executive talent, has introduced its newly redesigned website. This platform is not just a fresh coat of paint; it is crafted to enhance the understanding of the firm's innovative fractional executive model, honed to perfection over more than 20 years. Understanding Fractional Leadership The newly...
Continue Reading
Investing in Reliable Dividend Stocks When it comes to investing wisely, finding stocks that you can count on is crucial for a well-rounded portfolio. While each investor has their go-to picks, a few really stand out—Procter & Gamble (NYSE: PG), Hormel Foods (NYSE: HRL), and Hershey (NYSE: HSY). Often labeled as "never-sell" stocks, these companies are currently facing...
Continue Reading
Understanding the AI-Based Fraud Detection Tools Market The AI-based fraud detection tools market is experiencing substantial growth, propelled by the increasing recognition of the detrimental impacts of financial crimes. Organizations are becoming increasingly aware of the significant costs related to fraud—such as chargebacks, harm to reputation, and legal...
Continue Reading